• 28 February 2019

    Top therapy areas in biosimilar trials

    Over the past decade, the number of clinical trials using a biosimilar treatment has been on the rise. GlobalData extracted all biosimilar drug trials up to December 21, 2018 and...

  • 18 February 2019

    Lilly closes $8bn Loxo Oncology acquisition

    Eli Lilly has completed the acquisition of all outstanding shares of Loxo Oncology in a deal valued at approximately $8bn, boosting its oncology portfolio with precision medicines to potentially treat...

Go Top